Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Comparison of Sevikar® and the Combination of Perindopril/Amlodipine on Central Blood Pressure

This study has been completed.
Information provided by (Responsible Party):
Daiichi Sankyo Inc. ( Daiichi Sankyo Europe, GmbH ) Identifier:
First received: April 7, 2010
Last updated: January 14, 2013
Last verified: January 2013